Fell, M. J., Perry, K. W., Falcone, J. F., Johnson, B. G., Barth, V. N., Rash, K. S., . . . Nelson, D. L. (2009). In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268). The Journal of pharmacology and experimental therapeutics, 331(3), 1126-1136. https://doi.org/10.1124/jpet.109.160598
Chicago Style (17th ed.) CitationFell, Matthew J., et al. "In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268)." The Journal of Pharmacology and Experimental Therapeutics 331, no. 3 (2009): 1126-1136. https://doi.org/10.1124/jpet.109.160598.
MLA (9th ed.) CitationFell, Matthew J., et al. "In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268)." The Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 3, 2009, pp. 1126-1136, https://doi.org/10.1124/jpet.109.160598.